Updated data provided today by the US Centers for Disease Control reports over 800 cases of acute respiratory distress linked to the use of portable vapor cartridges used to consume certain e-liquids. Of the products tested thus far by the US Food and Drug Administration, about half have identified the presence of Vitamin E acetate.
Rather than use these unfortunate incidents as an opportunity to further drive these markets into the shadows, the administration should officially legalize cannabis and empower the FDA to better study, regulate, and oversee these emerging THC and CBD delivery devices — and to create regulatory standards for legal states to follow and enforce.
The US Centers for Disease Control has now identified over 450 cases of respiratory distress that may be associated with the use of disposable vapor cartridges used to consume certain e-liquids.
Washington, DC: The US Centers for Disease Control has now identified over 200 cases of…
Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019.
As more states legislatively address the topic of regulating medical cannabis access and distribution, NORML…
Cannabis smoke and tobacco smoke are not equally carcinogenic “Across the United States, there is…
Cannabis access is associated with reduced rates of opioid use and abuse, opioid-related hospitalizations, opioid-related…